Ember Therapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 05/16/2024

Stock Rating
0
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
$0.00
-

Ember Therapeutics Fair Value Forecast for 2023 - 2025 - 2030

Ember Therapeutics's Price has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next seven years, experts predict that Ember Therapeutics's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$0.00
2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$787.02 Buy/Sell $636.99 11.50%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$152.67 Buy/Sell $174.55 11.35%
MRK Stock Forecast Merck Outperform 2
$131.73 Buy/Sell $130.51 8.56%
PFE Stock Forecast Pfizer Outperform 2
$28.82 Buy/Sell $32.87 5.83%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$437.49 Buy/Sell $457.59 4.51%

Ember Therapeutics Revenue Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$978.21 Buy/Sell $961.26 7.34%
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$44.55 Buy/Sell $58.15 21.21%
ZTS Stock Forecast Zoetis Outperform 18
$173.28 Buy/Sell $220.47 26.96%

Ember Therapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$147.40 Buy/Sell $245.24 47.56%
BAX Stock Forecast Baxter International Inc Hold 17
$35.43 Buy/Sell $44.86 24.19%
VTRS Stock Forecast Viatris Inc Hold 8
$11.07 Buy/Sell $11.73 8.40%

Ember Therapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UTHR Stock Forecast United Therapeutics Outperform 12
$272.69 Buy/Sell $284.08 10.02%
CTLT Stock Forecast Catalent Hold 15
$55.61 Buy/Sell $49.29 14.19%
CYTK Stock Forecast Cytokinetics Outperform 10
$60.50 Buy/Sell $87.92 55.37%

Ember Therapeutics EBITDA Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$39.21 Buy/Sell $55.60 53.02%
BCPC Stock Forecast Balchem Outperform 18
$156.36 Buy/Sell $145.00 5.53%
MDGL Stock Forecast Madrigal Pharmaceuticals Outperform 4
$211.73 Buy/Sell $315.92 82.31%

Ember Therapeutics EBIT Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PRGO Stock Forecast Perrigo Co PLC Outperform 16
$30.22 Buy/Sell $44.75 32.36%
NEOG Stock Forecast Neogen Outperform 16
$13.30 Buy/Sell $37.00 27.82%
CORT Stock Forecast Corcept Therapeutics Buy 16
$27.83 Buy/Sell $35.67 43.73%

Ember Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

Ember Therapeutics's EPS has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next seven years, experts predict that Ember Therapeutics's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$0.00
2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INDV Stock Forecast Indivior PLC Buy 14
£13.85 Buy/Sell £28.89 123.32%
TGTX Stock Forecast TG Therapeutics Outperform 9
$17.72 Buy/Sell $29.44 94.70%
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$42.44 Buy/Sell $69.00 46.09%